|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kang CG, Lee HJ, Kim SH and Lee EO:
Zerumbone suppresses osteopontin-induced cell invasion through
inhibiting the FAK/AKT/ROCK pathway in human non-small cell lung
cancer A549 Cells. J Nat Prod. 79:156–160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen G, Umelo IA, Lv S, Teugels E, Fostier
K, Kronenberger P, Dewaele A, Sadones J, Geers C and De Grève J:
miR-146a inhibits cell growth, cell migration and induces apoptosis
in non-small cell lung cancer cells. PLoS One. 8:e603172013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma Y, Yu S, Zhao W, Lu Z and Chen J:
miR-27a regulates the growth, colony formation and migration of
pancreatic cancer cells by targeting Sprouty2. Cancer Lett.
298:150–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guttilla IK and White BA: Coordinate
regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast
cancer cells. J Biol Chem. 284:23204–23216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L
and Wang Z: MiR-27a modulates MDR1/P-glycoprotein expression by
targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol.
119:125–130. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu XZ, Wang KP, Song HJ, Xia JH, Jiang Y
and Wang YL: MiR-27a-3p promotes esophageal cancer cell
proliferation via F-box and WD repeat domain-containing 7 (FBXW7)
suppression. Int J Clin Exp Med. 8:15556–15562. 2015.PubMed/NCBI
|
|
9
|
Peng H, Wang X, Zhang P, Sun T, Ren X and
Xia Z: miR-27a promotes cell proliferation and metastasis in renal
cell carcinoma. Int J Clin Exp Pathol. 8:2259–2266. 2015.PubMed/NCBI
|
|
10
|
Tang W, Zhu J, Su S, Wu W, Liu Q, Su F and
Yu F: MiR-27 as a prognostic marker for breast cancer progression
and patient survival. PLoS One. 7:e517022012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiao B, He BX, Cai JH, Tao Q and King-Yin
Lam A: MicroRNA-27a-3p Modulates the Wnt/β-Catenin signaling
pathway to promote epithelial-mesenchymal transition in oral
squamous carcinoma stem cells by targeting SFRP1. Sci Rep.
7:446882017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakata W, Uemura M, Sato M, Fujita K,
Jingushi K, Ueda Y, Kitae K, Tsujikawa K and Nonomura N: Expression
of miR-27a-3p is an independent predictive factor for recurrence in
clear cell renal cell carcinoma. Oncotarget. 6:21645–21654. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li JM, Zhou J, Xu Z, Huang HJ, Chen MJ and
Ji JS: MicroRNA-27a-3p inhibits cell viability and migration
through down-regulating DUSP16 in hepatocellular carcinoma. J Cell
Biochem. 119:5143–5152. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang Y, Duan Y and Zhou H: MicroRNA-27a
directly targets KRAS to inhibit cell proliferation in esophageal
squamous cell carcinoma. Oncol Lett. 9:471–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eiró N and Vizoso FJ: Inflammation and
cancer. World J Gastrointest Surg. 4:62–72. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Butkiewicz D, Krześniak M, Drosik A,
Giglok M, Gdowicz-Kłosok A, Kosarewicz A, Rusin M, Masłyk B,
Gawkowska-Suwińska M and Suwiński R: The VEGFR2, COX-2 and MMP-2
polymorphisms are associated with clinical outcome of patients with
inoperable non-small cell lung cancer. Int J Cancer. 137:2332–2342.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boutsikou E, Domvri K, Hardavella G,
Tsiouda D, Zarogoulidis K and Kontakiotis T: Tumour necrosis
factor, interferon-gamma and interleukins as predictive markers of
antiprogrammed cell-death protein-1 treatment in advanced non-small
cell lung cancer: A pragmatic approach in clinical practice. Ther
Adv Med Oncol. 10:17588359187682382018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Chemokines and Relevant microRNAs in the Atherogenic Process.
Mini Rev Med Chem. 18:597–608. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kollmar O, Scheuer C, Menger MD and
Schilling MK: Macrophage inflammatory protein-2 promotes
angiogenesis, cell migration, and tumor growth in hepatic
metastasis. Ann Surg Oncol. 13:263–275. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schramm R and Thorlacius H: Neutrophil
recruitment in mast cell-dependent inflammation: Inhibitory
mechanisms of glucocorticoids. Inflamm Res. 53:644–652. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eide HA, Halvorsen AR, Sandhu V, Fåne A,
Berg J, Haakensen VD, Kure EH, Brustugun OT, Kiserud CE, Kyte JA
and Helland Å: Non-small cell lung cancer is characterised by a
distinct inflammatory signature in serum compared with chronic
obstructive pulmonary disease. Clin Transl Immunology. 5:e1092016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burgess M, Cheung C, Chambers L,
Ravindranath K, Minhas G, Knop L, Mollee P, McMillan NA and Gill D:
CCL2 and CXCL2 enhance survival of primary chronic lymphocytic
leukemia cells in vitro. Leuk Lymphoma. 53:1988–1998. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Doll D, Keller L, Maak M, Boulesteix AL,
Siewert JR, Holzmann B and Janssen KP: Differential expression of
the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and
their impact on metastatic disease and survival. Int J Colorectal
Dis. 25:573–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Armstrong DA, Major JA, Chudyk A and
Hamilton TA: Neutrophil chemoattractant genes KC and MIP-2 are
expressed in different cell populations at sites of surgical
injury. J Leukoc Biol. 75:641–648. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang N, Zhu S, Lv X, Qiao Y, Liu YJ and
Chen J: MicroRNAs: Pleiotropic regulators in the tumor
microenvironment. Front Immunol. 9:24912018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song Q, Li H, Shao H, Li C and Lu X:
MicroRNA-365 in macrophages regulates Mycobacterium
tuberculosis-induced active pulmonary tuberculosis via
interleukin-6. Int J Clin Exp Med. 8:15458–15465. 2015.PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen Y, Tsai YH and Tseng SH: The
potential of tetrandrine as a protective agent for ischemic stroke.
Molecules. 16:8020–8032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou L, Liang X, Zhang L, Yang L, Nagao N,
Wu H, Liu C, Lin S, Cai G and Liu J: MiR-27a-3p functions as an
oncogene in gastric cancer by targeting BTG2. Oncotarget.
7:51943–51954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang J, Tang J, Shi H, Li H, Zhen T, Duan
J, Kang L, Zhang F, Dong Y and Han A: miR-27a-3p targeting RXRα
promotes colorectal cancer progression by activating Wnt/β-catenin
pathway. Oncotarget. 8:82991–83008. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, Yang X, Liu M and Tang H: B4GALT3
up-regulation by miR-27a contributes to the oncogenic activity in
human cervical cancer cells. Cancer Lett. 375:284–292. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Parchami Barjui S, Reiisi S, Ebrahimi SO
and Shekari B: Study of correlation between genetic variants in
three microRNA genes (hsa-miR-146a, hsa-miR-502 binding site,
hsa-miR-27a) and breast cancer risk. Curr Res Transl Med.
65:141–147. 2017.PubMed/NCBI
|
|
33
|
Scheibner KA, Teaboldt B, Hauer MC, Chen
X, Cherukuri S, Guo Y, Kelley SM, Liu Z, Baer MR, Heimfeld S and
Civin CI: MiR-27a functions as a tumor suppressor in acute leukemia
by regulating 14-3-3θ. PLoS One. 7:e508952012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Haskill S, Peace A, Morris J, Sporn SA,
Anisowicz A, Lee SW, Smith T, Martin G, Ralph P and Sager R:
Identification of three related human GRO genes encoding cytokine
functions. Proc Natl Acad Sci USA. 87:7732–7736. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong QM, Zhang JQ, Li Q, Bracher JC,
Hendricks DT and Zhao XH: Clinical significance of serum expression
of GROβ in esophageal squamous cell carcinoma. World J
Gastroenterol. 17:2658–2662. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang H, Ye YL, Li MX, Ye SB, Huang WR,
Cai TT, He J, Peng JY, Duan TH, Cui J, et al: CXCL2/MIF-CXCR2
signaling promotes the recruitment of myeloid-derived suppressor
cells and is correlated with prognosis in bladder cancer. Oncogene.
36:2095–2104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu Y, Li S, Ma L, Li Y, Zhang X, Peng Q,
Mo C, Huang L, Qin X and Liu Y: Type conversion of secretomes in a
3D TAM2 and HCC cell co-culture system and functional importance of
CXCL2 in HCC. Sci Rep. 6:245582016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao H, Zhu H, Jin Q, Zhang S, Wang W,
Wang D and Huang J: Association of high expression of Groβ with
clinical and pathological characteristics of unfavorable prognosis
in gastrointestinal stromal tumors. Dis Markers. 2015:1710352015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kavandi L, Collier MA, Nguyen H and Syed
V: Progesterone and calcitriol attenuate inflammatory cytokines
CXCL1 and CXCL2 in ovarian and endometrial cancer cells. J Cell
Biochem. 113:3143–3152. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Keeley EC, Mehrad B and Strieter RM: CXC
chemokines in cancer angiogenesis and metastases. Adv Cancer Res.
106:91–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Luan J, Shattuck-Brandt R, Haghnegahdar H,
Owen JD, Strieter R, Burdick M, Nirodi C, Beauchamp D, Johnson KN
and Richmond A: Mechanism and biological significance of
constitutive expression of MGSA/GRO chemokines in malignant
melanoma tumor progression. J Leukoc Biol. 62:588–597. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bruyère C, Lonez C, Duray A, Cludts S,
Ruysschaert JM, Saussez S, Yeaton P, Kiss R and Mijatovic T:
Considering temozolomide as a novel potential treatment for
esophageal cancer. Cancer. 117:2004–2016. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ye Q, Zhai X, Wang W, Zhang S, Zhu H, Wang
D and Wang C: Overexpression of growth-related oncogene-β is
associated with tumorigenesis, metastasis, and poor prognosis in
ovarian cancer. Dis Markers. 2015:3873822015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Wang Y and Zhang P: Clinical
significance of serum expression of GROβ in hepatocellular
carcinoma. Tumour Biol. 36:6445–6449. 2015. View Article : Google Scholar : PubMed/NCBI
|
